M. Orlando
Alexander Fleming Institute
Buenos Aires
Argentina
Name/email consistency: high
- Low-dose continuous oral fosfestrol is highly active in 'hormone-refractory' prostate cancer. Orlando, M., Chacón, M., Salum, G., Chacón, D.R. Ann. Oncol. (2000)
 









